Drug Type Synthetic peptide |
Synonyms DPOCL, DermaPro, Woxheal + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date India (15 Apr 2017), |
Regulation- |
Molecular FormulaCl2O6 |
InChIKeyAOZVERGQFUXIRT-UHFFFAOYSA-N |
CAS Registry288389-48-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetic Foot | India | 15 Apr 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic foot ulcer | Phase 1 | Estonia | 06 Aug 2018 | |
Leg Ulcer | Phase 1 | United States | - | 03 Aug 2017 |
Diabetic Foot | Phase 1 | Latvia | - | 16 Sep 2013 |
Burns | Preclinical | Germany | - | - |